Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Blueprint Medicines Corporation - Common Stock
(NQ:
BPMC
)
129.46
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Blueprint Medicines Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
↗
May 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 01, 2024
Via
Benzinga
The Analyst Verdict: Blueprint Medicines In The Eyes Of 7 Experts
↗
April 26, 2024
Via
Benzinga
Decoding 6 Analyst Evaluations For Blueprint Medicines
↗
April 10, 2024
Via
Benzinga
(BPMC) - Analyzing Blueprint Medicines's Short Interest
↗
February 20, 2024
Via
Benzinga
Earnings Scheduled For February 15, 2024
↗
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
Blueprint Medicines's Earnings Outlook
↗
February 14, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Blueprint Medicines
↗
February 13, 2024
Via
Benzinga
Blueprint Medicines Corp. (NASDAQ: BPMC) Climbs to New 52-Week High
February 16, 2024
Via
Investor Brand Network
Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday
↗
February 15, 2024
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.
Via
Benzinga
Topics
Stocks
Blueprint Medicines Outranks 92% Of All Stocks. But This Could Be Its Undoing.
↗
February 15, 2024
The company reported better-than-expected sales of its rare-disease drug, but there's one drawback in its report.
Via
Investor's Business Daily
Peeling Back The Layers: Exploring Blueprint Medicines Through Analyst Insights
↗
January 09, 2024
Via
Benzinga
The Latest Analyst Ratings for Blueprint Medicines
↗
December 11, 2023
Via
Benzinga
Needham Maintains Buy Rating for Blueprint Medicines: Here's What You Need To Know
↗
October 27, 2023
Via
Benzinga
Blueprint Medicines's Earnings: A Preview
↗
October 25, 2023
Via
Benzinga
Raymond James Maintains Strong Buy Rating for Blueprint Medicines: Here's What You Need To Know
↗
December 22, 2023
Via
Benzinga
Chart Of The Day: Does Blueprint Medicines Have A Blueprint For Success?
↗
December 13, 2023
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
Via
Talk Markets
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
December 11, 2023
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the...
Via
Benzinga
Analyst Ratings for Blueprint Medicines
↗
August 21, 2023
Via
Benzinga
What 15 Analyst Ratings Have To Say About Blueprint Medicines
↗
August 02, 2023
Via
Benzinga
Why Shares of Blueprint Medicines Are Falling Wednesday
↗
August 02, 2023
The company had generally improved earnings.
Via
The Motley Fool
A Preview Of Blueprint Medicines's Earnings
↗
August 01, 2023
Via
Benzinga
Barclays Maintains Equal-Weight Rating for Blueprint Medicines: Here's What You Need To Know
↗
October 27, 2023
Via
Benzinga
Why Blueprint Medicines Stock Soared Today
↗
October 26, 2023
The precision-treatment company saw stronger-than-expected sales in its first full quarter following the launch of Ayvakit.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 26, 2023
Via
Benzinga
Blueprint Medicines Corp. (NASDAQ: BPMC) Leading the Way in Thursday Trading Based on Percentage Gain
October 26, 2023
Via
Investor Brand Network
Unpacking Blueprint Medicines' Ayvakit's Bright Future: Insights From Latest Physician Survey On Sales Predictions
↗
August 21, 2023
Needham slightly increased the price target for Blueprint Medicines Corp (NASDAQ: BPMC) from $65 to $66
Via
Benzinga
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
October 26, 2023
Gainers
Via
Benzinga
IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday
↗
October 26, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
↗
July 31, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
